Subcutaneous Adipocyte Lipolysis Contributes to Circulating Lipid Levels

Objective— Fatty acids released via fat cell lipolysis can affect circulating lipid levels. However, the contribution of different lipolysis measures in adipose tissue is unknown and was presently examined in isolated subcutaneous adipocytes. Approach and Results— One thousand and sixty-six men and women were examined for lipolysis regulation in subcutaneous abdominal fat cells. Results were compared with fasting plasma levels of total cholesterol, high-density lipoprotein (HDL) cholesterol (HDL-C) and triglycerides. Spontaneous (basal) lipolysis and the effects of the major hormones stimulating (catecholamines and natriuretic peptides) and inhibiting lipolysis (insulin) were examined. Several statistically significant (P<0.0001) correlations between the different lipolysis parameters and plasma lipids were observed. However, physiologically relevant correlations (adjusted r2≥0.05) were only evident between basal or insulin-inhibited lipolysis and plasma triglycerides or HDL-C. Together, these lipolysis measures explained 14% of the variation in triglycerides or HDL-C, respectively. In comparison, a combination of established factors associated with variations in plasma lipids, that is, age; body mass index; waist circumference; waist-to-hip ratio; sex; nicotine use; fat cell volume; and pharmacotherapy against diabetes mellitus; hypertension; or hyperlipidemia explained 17% and 28%, respectively, of the variations in plasma triglycerides and HDL-C. Conclusions— Subcutaneous fat cell lipolysis is an important independent contributor to interindividual variations in plasma lipids. High spontaneous lipolysis activity and resistance to the antilipolytic effect of insulin associate with elevated triglyceride and low HDL-C concentrations. Thus, although several other factors also play a role, subcutaneous adipose tissue may have a causal influence on dyslipidemia.

[1]  P. Arner,et al.  Long-term Protective Changes in Adipose Tissue After Gastric Bypass , 2016, Diabetes Care.

[2]  H. Grallert,et al.  Effects of Genetic Loci Associated with Central Obesity on Adipocyte Lipolysis , 2016, PloS one.

[3]  Andrew W Dake,et al.  Diabetic Dyslipidemia Review: An Update on Current Concepts and Management Guidelines of Diabetic Dyslipidemia☆ , 2016, The American journal of the medical sciences.

[4]  B. Nordestgaard.  Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease: New Insights From Epidemiology, Genetics, and Biology. , 2016, Circulation research.

[5]  I. Ramasamy.  Update on the molecular biology of dyslipidemias. , 2016, Clinica chimica acta; international journal of clinical chemistry.

[6]  B. Sears,et al.  The role of fatty acids in insulin resistance , 2015, Lipids in Health and Disease.

[7]  R. McPherson,et al.  Gene–environment interaction in dyslipidemia , 2015, Current opinion in lipidology.

[8]  P. Arner,et al.  Fatty Acids, Obesity and Insulin Resistance , 2015, Obesity Facts.

[9]  S. Rössner,et al.  Adipose tissue morphology predicts improved insulin sensitivity following moderate or pronounced weight loss , 2015, International Journal of Obesity.

[10]  P. Arner,et al.  Lipolysis in lipid turnover, cancer cachexia, and obesity-induced insulin resistance , 2014, Trends in Endocrinology & Metabolism.

[11]  B. Klop,et al.  Dyslipidemia in Obesity: Mechanisms and Potential Targets , 2013, Nutrients.

[12]  R. Nelson,et al.  Hyperlipidemia as a risk factor for cardiovascular disease. , 2013, Primary care.

[13]  Yuanyuan Wu,et al.  Adipose tissue heterogeneity: implication of depot differences in adipose tissue for obesity complications. , 2013, Molecular aspects of medicine.

[14]  M. Jensen,et al.  Fat Depots, Free Fatty Acids, and Dyslipidemia , 2013, Nutrients.

[15]  S. Bernard,et al.  Adipocyte Triglyceride Turnover Is Independently Associated With Atherogenic Dyslipidemia , 2012, Journal of the American Heart Association.

[16]  S. Bernard,et al.  Dynamics of human adipose lipid turnover in health and metabolic disease , 2011, Nature.

[17]  P. Jansson,et al.  Impaired delivery of insulin to adipose tissue and skeletal muscle in obese women with postprandial hyperglycemia. , 2011, The Journal of clinical endocrinology and metabolism.

[18]  G. Lewis,et al.  Plasma nonesterified Fatty Acid intolerance and hyperglycemia are associated with intravenous lipid-induced impairment of insulin sensitivity and disposition index. , 2010, The Journal of clinical endocrinology and metabolism.

[19]  S. Bernard,et al.  Adipocyte Turnover: Relevance to Human Adipose Tissue Morphology , 2009, Diabetes.

[20]  M. Jensen.  Role of body fat distribution and the metabolic complications of obesity. , 2008, The Journal of clinical endocrinology and metabolism.

[21]  J. Girard,et al.  Impact of visceral adipose tissue on liver metabolism. Part I: heterogeneity of adipose tissue and functional properties of visceral adipose tissue. , 2008, Diabetes & metabolism.

[22]  G. Lewis,et al.  Both Intestinal and Hepatic Lipoprotein Production Are Stimulated by an Acute Elevation of Plasma Free Fatty Acids in Humans , 2008, Circulation.

[23]  P. Arner,et al.  Tumour necrosis factor‐α in human adipose tissue – from signalling mechanisms to clinical implications , 2007, Journal of internal medicine.

[24]  P. Arner,et al.  Mechanism of increased lipolysis in cancer cachexia. , 2007, Cancer research.

[25]  J. Kastelein,et al.  The role of CETP inhibition in dyslipidemia , 2007, Current atherosclerosis reports.

[26]  D. Langin.  Adipose tissue lipolysis as a metabolic pathway to define pharmacological strategies against obesity and the metabolic syndrome. , 2006, Pharmacological research.

[27]  P. Arner,et al.  Prospective and controlled studies of the actions of insulin and catecholamine in fat cells of obese women following weight reduction , 2005, Diabetologia.

[28]  F. Crampes,et al.  An Unsuspected Metabolic Role for Atrial Natriuretic Peptides: The Control of Lipolysis, Lipid Mobilization, and Systemic Nonesterified Fatty Acids Levels in Humans , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[29]  T. Kenakin.  Principles: receptor theory in pharmacology. , 2004, Trends in pharmacological sciences.

[30]  J. Rotter,et al.  Evidence of insulin resistant lipid metabolism in adipose tissue in familial combined hyperlipidemia, but not type 2 diabetes mellitus. , 2002, Atherosclerosis.

[31]  J. Hokanson,et al.  The contribution of intraabdominal fat to gender differences in hepatic lipase activity and low/high density lipoprotein heterogeneity. , 2001, The Journal of clinical endocrinology and metabolism.

[32]  M. Uusitupa,et al.  Concordance of in vivo microdialysis and in vitro techniques in the studies of adipose tissue metabolism , 2000, International Journal of Obesity.

[33]  Y. Marcel,et al.  Biochemical and physical properties of remnant-HDL2 and of pre beta 1-HDL produced by hepatic lipase. , 1999, Biochemistry.

[34]  V. Large,et al.  Sex differences in visceral fat lipolysis and metabolic complications of obesity. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[35]  G. Lewis.  Fatty acid regulation of very low density lipoprotein production. , 1997, Current opinion in lipidology.

[36]  R N Pierson,et al.  How useful is body mass index for comparison of body fatness across age, sex, and ethnic groups? , 1996, American journal of epidemiology.

[37]  M. Eriksson,et al.  Impaired activation of adipocyte lipolysis in familial combined hyperlipidemia. , 1995, The Journal of clinical investigation.

[38]  U. Smith,et al.  Measurement by Microdialysis of the Insulin Concentration in Subcutaneous Interstitial Fluid: Importance of the Endothelial Barrier for Insulin , 1993, Diabetes.

[39]  H. Kather,et al.  Pathways of purine metabolism in human adipocytes. Further evidence against a role of adenosine as an endogenous regulator of human fat cell function. , 1990, The Journal of biological chemistry.

[40]  P. Arner,et al.  Automatic luminometric kinetic assay of glycerol for lipolysis studies. , 1989, Analytical biochemistry.

[41]  M. Taskinen,et al.  Interrelationships Among Insulin's Antilipolytic and Glucoregulatory Effects and Plasma Triglycerides in Nondiabetic and Diabetic Patients With Endogenous Hypertriglyceridemia , 1988, Diabetes.

[42]  P. Arner,et al.  Changes in the metabolism of fatty acids in adipose tissue in obese patients with primary hypertriacylglycerolemia. , 1982, Journal of lipid research.

[43]  P. Cryer.  Physiology and pathophysiology of the human sympathoadrenal neuroendocrine system. , 1980, The New England journal of medicine.

[44]  A. Kissebah,et al.  Role of insulin resistance in adipose tissue and liver in the pathogenesis of endogenous hypertriglyceridaemia in man , 1976, Diabetologia.

[45]  L. Sjöström,et al.  Adipocyte metabolism in endogenous hypertriglyceridemia. , 1975, Metabolism: clinical and experimental.

[46]  A. Kissebah,et al.  Plasma free fatty acid and triglyceride transport kinetics in man. , 1974, Clinical science and molecular medicine.

[47]  R. Havel,et al.  Splanchnic metabolism of free fatty acids and production of triglycerides of very low density lipoproteins in normotriglyceridemic and hypertriglyceridemic humans. , 1970, The Journal of clinical investigation.

[48]  G. Lewis,et al.  The mechanism of HDL lowering in hypertriglyceridemic, insulin-resistant states. , 2002, Journal of diabetes and its complications.

[49]  H. Kotake,et al.  [Endogenous hypertriglyceridemia]. , 2001, Nihon rinsho. Japanese journal of clinical medicine.

[50]  R. Considine,et al.  A new technique for biopsy of human abdominal fat under local anaesthesia with Lidocaine. , 1994, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[51]  F. Lönnqvist,et al.  Antilipolytic effects of insulin and adenylate cyclase inhibitors on isolated human fat cells. , 1989, International journal of obesity.